scholarly journals Induction of Cytochrome P450 2A6 by Bilirubin in Human Hepatocytes

2013 ◽  
Vol 04 (02) ◽  
pp. 182-190 ◽  
Author(s):  
Hiromi Tanii ◽  
Yoshihisa Shitara ◽  
Mikako Torii ◽  
Shuichi Sekine ◽  
Hiroshi Iwata ◽  
...  
Xenobiotica ◽  
2009 ◽  
Vol 00 (00) ◽  
pp. 090901052053001-8
Author(s):  
K. Murai ◽  
H. Yamazaki ◽  
K. Nakagawa ◽  
R. Kawai ◽  
T. Kamataki

2019 ◽  
Vol 20 (9) ◽  
pp. 765-770 ◽  
Author(s):  
Hana M. Hammad ◽  
Amer Imraish ◽  
Belal Azab ◽  
Al M. Best ◽  
Yousef S. Khader ◽  
...  

Background: Cytochrome P450 2A6 enzyme (CYP2A6), an essential hepatic enzyme involved in the metabolism of drugs, is responsible for a major metabolic pathway of nicotine. Variation in the activity of polymorphic CYP2A6 alleles has been implicated in inter-individual differences in nicotine metabolism. Aims: The objective of the current study was to assess the association between the smoking status and the cytochrome P450 2A6 enzyme (CYP2A6) genotype in Jordanians. Methods: In the current study, 218 (117 Male and 101 female) healthy unrelated Jordanian volunteers were recruited. CYP2A6*1B, CYP2A6*4 and CYP2A6*9 were determined and correlated with subject smoking status. Results: *1A/*1A was the most common genetic polymorphism in the overall study population, with no significant frequency differences between smokers and non-smokers. When the population was divided according to gender, only male smokers showed a significant correlation between genotype and smoking status. Considering the CYP2A6*9 genotype, the results showed differences in distribution between smokers and non-smokers, but only women showed a significant association between CYP2A6*9 allele genotype and smoking status. Conclusion: The results of this study show that there is a significant association between CYP2A6*9 genotype and smoking status. They also show that CYP2A6 genotype is significantly influenced by gender.


2012 ◽  
Vol 6 (2) ◽  
pp. 67-72 ◽  
Author(s):  
Miyuki Kimura ◽  
Makiko Shimizu ◽  
Kazuma Kiyotani ◽  
Kazuko Nakagawa ◽  
Tetsuya Kamataki ◽  
...  

Toxicology ◽  
2008 ◽  
Vol 243 (1-2) ◽  
pp. 84-95 ◽  
Author(s):  
Roger J. Price ◽  
Amanda M. Giddings ◽  
Mary P. Scott ◽  
David G. Walters ◽  
Charles C. Capen ◽  
...  

Xenobiotica ◽  
2021 ◽  
pp. 1-47
Author(s):  
Haruna Nagayoshi ◽  
Norie Murayama ◽  
Shigeo Takenaka ◽  
Vitchan Kim ◽  
Donghak Kim ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Douglas MacPherson ◽  
Yaron Bram ◽  
Jiwoon Park ◽  
Robert E. Schwartz

AbstractWe report here the use of a nanofibrous hydrogel as a 3D scaffold for the culture and maintenance of functional primary human hepatocytes. The system is based on the cooperative assembly of a fiber-forming peptide component, fluorenylmethyloxycarbonyl-diphenylalanine (Fmoc-FF), and the integrin-binding functional peptide ligand, Fmoc-arginine-glycine-aspartic acid (Fmoc-RGD) into a nanofibrous gel at physiological pH. This Fmoc-FF/RGD hydrogel was formulated to provide a biomimetic microenvironment with some critical features such as mechanical properties and nanofiber morphology, which were optimized to support hepatocyte culture. The material was shown to support maintenance and function of encapsulated primary human hepatocytes as indicated by actin staining, qRT-PCR, and functional cytochrome P450 assays. The designed gel was shown to outperform Matrigel in cytochrome P450 functional assays. The hydrogel may prove useful for liver development and disease models, as well as providing insights into the design of future implantable scaffolds for the regeneration of liver tissue in patients with liver disease.


Xenobiotica ◽  
2012 ◽  
Vol 42 (10) ◽  
pp. 968-979 ◽  
Author(s):  
Eliane Alexandre ◽  
Audrey Baze ◽  
Céline Parmentier ◽  
Coraline Desbans ◽  
Dumrongsak Pekthong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document